Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ruijie Dang, Meiling Jin, Jingzhu Nan, Xuege Jiang, Zheng He, Fang Su & Diangeng Li. (2022) A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma. International Journal of General Medicine 15, pages 207-222.
Read now
Read now
Articles from other publishers (4)
Zhaoyang Yan, Juntao Lu, Xinjian Xu, Yang You, Jinsheng XuTongxin Xu. (2022) The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA). Medicine 101:39, pages e30789.
Crossref
Crossref
Xiang Liu, Wei Zeng, Dayang Zheng, Min Tang & Wangyan Zhou. (2022) Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset. Medicine 101:37, pages e30440.
Crossref
Crossref
Yuwei Pu, Jinrong Wei, Yong Wu, Kui Zhao, Yongyou Wu, Shu Wu, Xiaodong Yang & Chungen Xing. (2022) THUMPD3-AS1 facilitates cell growth and aggressiveness by the miR-218-5p/SKAP1 axis in colorectal cancer. Cell Biochemistry and Biophysics 80:3, pages 483-494.
Crossref
Crossref
Hongfei Guo, Tao Li, Chunlei Peng, Qinghua Mao, Biao Shen, Minxin Shi, Haimin Lu, Ting Xiao, Aimin Yang & Yupeng Liu. (2022)
Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
via
regulating the miR-587/bone morphogenetic protein 3 axis in lung adenocarcinoma
. Human & Experimental Toxicology 41, pages 096032712211389.
Crossref
Crossref